MARIZYME INC | Business Contracts

Securities Purchase Agreement, dated as of February 6, 2023, by and between Marizyme, Inc. and Walleye Opportunities Master Fund Ltd (Filed With SEC on February 7, 2023)

Letter Agreement between Marizyme, Inc. and Univest Securities, LLC, dated January 12, 2023 (Filed With SEC on January 17, 2023)

Form of Restricted Stock Award Agreement for Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (Filed With SEC on November 2, 2022)

Form of Indemnification Agreement between Marizyme, Inc. and each current officer or director (Filed With SEC on November 2, 2022)

First Amendment to Lease, dated March 16, 2022, between JIC Equities, LLC and Marizyme, Inc., dated (Filed With SEC on August 15, 2022)

Class D Common Stock Purchase Warrant issued by Marizyme, Inc (Filed With SEC on February 7, 2023)

Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc., dated February 6, 2023 (Filed With SEC on February 7, 2023)

Form of Warrant Agent Agreement (Filed With SEC on February 1, 2023)

Form of Unit Warrant (Filed With SEC on February 1, 2023)

Promissory Note issued by Marizyme, Inc. to Hexin Global Ltd., dated December 28, 2022 (Filed With SEC on February 1, 2023)

Waiver and Consent between Marizyme, Inc. and Viner Total Investments Fund, dated January 9, 2023 (Filed With SEC on January 17, 2023)

Form of Underwriting Agreement (Filed With SEC on November 2, 2022)

Common Stock Purchase Warrant issued to AAT Services Inc., dated December 21, 2021 (Filed With SEC on November 2, 2022)

Common Stock Purchase Warrant issued to Rydra Capital Corp., dated December 21, 2021 (Filed With SEC on November 2, 2022)

Form of Warrant (Filed With SEC on November 2, 2022)

Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (Filed With SEC on November 2, 2022)

Form of Stock Option Agreement for Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (Filed With SEC on November 2, 2022)

Form of Independent Director Agreement between Marizyme, Inc. and each current non-executive director (Filed With SEC on November 2, 2022)

Form of Restricted Stock Unit Award Agreement for Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (Filed With SEC on November 2, 2022)

Agreement to Transfer Option and Amendatory Agreement, among Marizyme, Inc., James Sapirstein and Bevilacqua PLLC as escrow agent, dated March 3, 2022 (Filed With SEC on November 2, 2022)

Waiver, dated July 22, 2022, between Marizyme, Inc. and Viner Total Investments Fund (Filed With SEC on November 2, 2022)

Waiver, dated July 22, 2022, between Marizyme, Inc. and Waichun Logistics Technology Limited (Filed With SEC on November 2, 2022)

Form of Limited Waiver and Consent between Marizyme, Inc. and certain investors (Filed With SEC on November 2, 2022)

Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated August 12, 2022 (Filed With SEC on August 18, 2022)

10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated August 12, 2022 (Filed With SEC on August 18, 2022)

Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated June 17, 2022 (Filed With SEC on August 15, 2022)

Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated June 17, 2022 (Filed With SEC on August 15, 2022)

Form of Placement Agent Warrants issued on June 26, 2022 (Filed With SEC on August 15, 2022)

Agreement to Transfer Option and Amendatory Agreement, among Marizyme, Inc., James Sapirstein and Bevilacqua PLLC as escrow agent, dated March 3, 2022 (Filed With SEC on May 16, 2022)

Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated March 24, 2022 (Filed With SEC on May 16, 2022)

Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated March 24, 2022 (Filed With SEC on May 16, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated February 14, 2022 (Filed With SEC on May 16, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated January 26, 2022 (Filed With SEC on May 16, 2022)

Description of Securities of Marizyme, Inc (Filed With SEC on March 31, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated January 26, 2022 (Filed With SEC on March 31, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated February 14, 2022 (Filed With SEC on March 31, 2022)

Incentive Stock Option Agreement with George Kovalyov, dated March 17, 2022 (Filed With SEC on March 31, 2022)

Incentive Stock Option Agreement with Harrison Ross, dated March 17, 2022 (Filed With SEC on March 31, 2022)

Incentive Stock Option Agreement with Bradley Richmond, dated March 17, 2022 (Filed With SEC on March 31, 2022)

Indemnification Agreement dated November 1, 2020 with James Sapirstein (Filed With SEC on March 31, 2022)

Indemnification Agreement dated November 1, 2020 with Bruce Harmon (Filed With SEC on March 31, 2022)

Services Agreement dated March 1, 2021 between Marizyme, Inc. and James Sapirstein (Filed With SEC on March 31, 2022)

Director Agreement, dated as of December 6, 2018, between Marizyme, Inc. and James Sapirstein (Filed With SEC on March 31, 2022)

Agreement to Transfer Option and Amendatory Agreement, dated March 3, 2022, between Marizyme, Inc., James Sapirstein and Bevilacqua PLLC, as escrow agent (Filed With SEC on March 31, 2022)

Consulting Agreement, dated December 21, 2021, by and among Marizyme, Inc., Rydra Capital Corp., and Harrison Ross (Filed With SEC on February 14, 2022)

(Filed With SEC on February 14, 2022)

Confidential Separation Agreement and General Release, dated September 14, 2021, between Marizyme, Inc. and Roger Schaller (Filed With SEC on February 14, 2022)

Stock Option Agreement, dated January 16, 2021, between Marizyme, Inc. and Roger Schaller (Filed With SEC on February 14, 2022)

Employment Offer Letter, dated January 16, 2021, between Marizyme, Inc. and Roger Schaller (Filed With SEC on February 14, 2022)

Marizyme Employment Terms and Conditions Agreement, dated February 25, 2021, between Marizyme, Inc. and Roger Schaller (Filed With SEC on February 14, 2022)

Stock Option Agreement, dated January 29, 2021, between Marizyme, Inc. and Amy Chandler (Filed With SEC on February 14, 2022)

Marizyme Employment Terms and Conditions Agreement, dated January 18, 2021, between Marizyme, Inc. and Amy Chandler (Filed With SEC on February 14, 2022)

Executive Employment Agreement, dated July 26, 2021, between Marizyme, Inc. and Catherine Pachuk (Filed With SEC on February 14, 2022)

Lease, dated December 11, 2020, between JIC Equities, LLC and Marizyme, Inc (Filed With SEC on February 14, 2022)

Letter Agreement, dated March 5, 2021, between Marizyme, Inc. and Bruce Harmon (Filed With SEC on February 14, 2022)

Consulting Agreement, dated September 30, 2020, by and between Marizyme, Inc. and Bradley Richmond (Filed With SEC on February 14, 2022)

Form of Patent Security Agreement, dated as of May 19, 2021, between Marizyme, Inc. and the secured parties signatory thereto (Filed With SEC on February 14, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated October 2, 2020 (Filed With SEC on February 14, 2022)

Stock Option Agreement with James Sapirstein dated June 12, 2019 (Filed With SEC on February 14, 2022)

Stock Option Agreement with Terry Brostowin dated December 6, 2018 (Filed With SEC on February 14, 2022)

Stock Option Agreement with Frank Maresca dated January 9, 2020 (Filed With SEC on February 14, 2022)

Stock Option Agreement with James Sapirstein dated July 13, 2019 (Filed With SEC on February 14, 2022)

Stock Option Agreement with Terry Brostowin dated July 13, 2019 (Filed With SEC on February 14, 2022)

Stock Option Agreement with Frank Maresca dated July 13, 2019 (Filed With SEC on February 14, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated January 24, 2022 (Filed With SEC on February 14, 2022)

Mutual Release of Claims Agreement by and between Marizyme, Inc. and Nicholas DeVito dated August 27, 2020 (Filed With SEC on February 14, 2022)

Form of Guarantors Security Agreement, dated as of May 20, 2021, between Marizyme Sciences, Inc., Somaceutica, Inc., and Somahlution, Inc., and the secured parties signatory... (Filed With SEC on February 14, 2022)

Form of Guaranty, dated as of May 19, 2021, of Marizyme Sciences, Inc., Somaceutica, Inc., and Somahlution, Inc (Filed With SEC on February 14, 2022)

Form of Security Agreement, dated as of May 25, 2021, between Marizyme, Inc. and the secured parties signatory thereto (Filed With SEC on February 14, 2022)

Form of Trademark Security Agreement, dated as of May 19, 2021, between Marizyme, Inc. and the secured parties signatory thereto (Filed With SEC on February 14, 2022)

Common Stock Purchase Warrant issued to Univest Securities, LLC, dated January 24, 2022 (Filed With SEC on February 14, 2022)

Amendment to Executive Employment Agreement, dated as of February 8, 2022, between Marizyme, Inc. and David Barthel (Filed With SEC on February 9, 2022)

Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc (Filed With SEC on December 27, 2021)

Form of Unit Purchase Agreement between Marizyme, Inc. and the investors signatory thereto (Filed With SEC on December 27, 2021)

Form of Registration Rights Agreement between Marizyme, Inc. and the investors signatory thereto (Filed With SEC on December 27, 2021)

Consulting Agreement, dated December 21, 2021, by and among Marizyme, Inc., AAT Services Inc., and George Kovalyov (Filed With SEC on December 27, 2021)

Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc (Filed With SEC on December 27, 2021)

Form of Exchange Agreement between Marizyme, Inc. and the person executing the signature page thereto (Filed With SEC on December 27, 2021)

Placement Agency Agreement between Marizyme, Inc. and Univest Securities, LLC, dated December 10, 2021 (Filed With SEC on December 27, 2021)

Executive Employment Agreement (Filed With SEC on November 16, 2021)

Form of Class A Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)

Form of Unit Purchase Agreement, dated May 2021 (Filed With SEC on August 23, 2021)

Form of 10% Secured Convertible Promissory Note Agreement (Filed With SEC on August 23, 2021)

Form of Class B Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)

Form of Placement Agency Agreement (Filed With SEC on August 23, 2021)

Form of Placement Agent Warrant Agreement (Filed With SEC on August 23, 2021)

Consulting Agreement between Marizyme, Inc. and Lakeport Business Services, Inc. (Bruce Harmon) dated August 27, 2020 (Filed With SEC on April 15, 2021)

Offer Letter between Marizyme, Inc. and Roger Schaller dated January 16, 2021 (Filed With SEC on April 15, 2021)

Offer Letter between Marizyme, Inc. and Dr. Donald Very dated December 2, 2020 (Filed With SEC on April 15, 2021)

Offer Letter between Marizyme, Inc. and Dr. Steven Brooks dated December 1, 2020 (Filed With SEC on April 15, 2021)

Services Agreement dated March 1, 2021 between Marizyme, Inc. and James Sapirstein (Filed With SEC on April 15, 2021)

Marizyme, Inc. 2021 Stock Incentive Plan (Filed With SEC on April 15, 2021)

Indemnification Agreement dated November 1, 2020 with Bruce Harmon (Filed With SEC on April 15, 2021)

Indemnification Agreement dated November 1, 2020 with Terry Brostowin (Filed With SEC on April 15, 2021)

Indemnification Agreement dated November 1, 2020 with James Sapirstein (Filed With SEC on April 15, 2021)

INDEMNIFICATION AGREEMENT (Filed With SEC on November 16, 2020)

(Filed With SEC on August 14, 2020)

SUBSCRIPTION AGREEMENT To subscribe for shares of Common Stock in the private offering of MARIZYME, INC. (Filed With SEC on August 14, 2020)

PLACEMENT AGENT WARRANT MARIZYME, INC. (Filed With SEC on August 14, 2020)

AMENDMENT NO. 3 TO ASSET PURCHASE AGREEMENT DATED DECEMBER 15, 2019 (Filed With SEC on August 5, 2020)

LICENSING and DISTRIBUTION AGREEMENT (Filed With SEC on June 5, 2020)

AMENDMENT 2 to the ASSET PURCHASE AGREEMENT Dated May 29, 2020 (Filed With SEC on June 5, 2020)

AMENDMENT 1 to the ASSET PURCHASE AGREEMENT Dated December 15, 2019 (Filed With SEC on June 5, 2020)

EMPLOYMENT AGREEMENT (Filed With SEC on February 25, 2020)

ASSET PURCHASE AGREEMENT (Filed With SEC on December 19, 2019)

MARIZYME, INC. INCENTIVE STOCK OPTION AGREEMENT 2019 E QUITY INCENTIVE PLAN (Filed With SEC on November 13, 2019)

LICENSING and DISTRIBUTION AGREEMENT (Filed With SEC on November 13, 2019)

MARIZYME, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on July 3, 2019)

MARIZYME, INC. COMMON SHARE PURCHASE WARRANT (Filed With SEC on July 3, 2019)

DIRECTOR AGREEMENT (Filed With SEC on March 5, 2019)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 5, 2019)

MARIZYME INC (116)